| Literature DB >> 32309323 |
Shan Lu1, Anzhi Wang2, Shumei Miao3, Xin Zhang3, Shenqi Jing3, Tao Shan3, Yongan Guo2, Yun Liu3.
Abstract
BACKGROUND: Evidence of a role for type 2 diabetes in overall cancer risk is limited in ethnic Chinese populations. We therefore investigated whether there is an association between diabetes and cancer incidence.Entities:
Keywords: Diabetes; big data; cancer incidence; statistical analysis
Year: 2020 PMID: 32309323 PMCID: PMC7154402 DOI: 10.21037/atm.2020.01.101
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
The analysis of diabetes patients from 2006 to 2013
| Variable | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | |||||||||
| Total | 18,624 | 18,481 | 25,947 | 25,323 | 26,666 | 27,233 | 28,544 | 33,661 | 31,943 | 37,358 | 34,694 | 42,927 | 38,144 | 49,128 | 39,328 | 53,683 | ||||||||
| No. of diabetes cases | 411 | 2,011 | 583 | 3,028 | 705 | 3,368 | 797 | 4,203 | 930 | 4,787 | 1,210 | 5,699 | 1,931 | 6,824 | 1,993 | 7,711 | ||||||||
| P | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | ||||||||||||||||
| OR | 4.93 | 5.32 | 4.68 | 4.47 | 4.40 | 3.81 | 2.74 | 2.83 | ||||||||||||||||
| No. of cancer cases | 3,400 | 5,981 | 4,553 | 8,099 | 5,022 | 9,173 | 6,002 | 11,438 | 6,935 | 13,001 | 8,176 | 15,177 | 9,266 | 17,678 | 10,469 | 20,130 | ||||||||
| P | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | ||||||||||||||||
| OR | 1.77 | 1.82 | 1.79 | 1.62 | 1.60 | 1.50 | 8 | 1.41 | ||||||||||||||||
OR, odds ratio.
Baseline characteristics of diabetes and diabetes with cancer patients of hospitalized patients from 2006 to 2013
| Characteristics | DM (N=46,191) | DM & cancer (N=6,001) | P value |
|---|---|---|---|
| Female gender, N (%) | 19,611 (42.5) | 2,266 (37.8) | <0.005 |
| Age, mean (years) | 63.2 | 65.5 | <0.005 |
| Married status, N (%) | 0.15 | ||
| Married | 44,277 (95.9) | 5,915 (98.6) | |
| Single | 1,267 (2.7) | 36 (0.6) | |
| Divorced or widowed | 647 (1.4) | 647 (10.8) | |
| Medical insurance, N (%) | <0.005 | ||
| Rural cooperative insurance | 16,391 (35.5) | 1,948 (32.5) | |
| Urban resident insurance | 17,302 (37.5) | 2,089 (34.8) | |
| No insurance | 7,524 (16.3) | 1,377 (22.9) | |
| Others | 4,974 (10.8) | 587 (9.8) |
DM, diabetes mellitus.
The gender analysis of diabetes with cancer patients from 2006 to 2013
| Variable | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | ||||||||
| Diabetes or cancer | 5,256 | 4,957 | 6,788 | 7,005 | 7,599 | 7,902 | 9,215 | 9,677 | 10,447 | 11,015 | 12,246 | 12,863 | 14,475 | 14,475 | 16,223 | 16,580 | |||||||
| Diabetes & cancer | 123 | 97 | 175 | 156 | 215 | 185 | 302 | 225 | 428 | 232 | 562 | 341 | 875 | 462 | 1,055 | 568 | |||||||
| P | 0.191 | 0.189 | 0.062 | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | |||||||||||||||
| OR | 1.20 | 1.16 | 1.21 | 1.41 | 1.95 | 1.73 | 1.89 | 1.90 | |||||||||||||||
OR, odds ratio.
The age analysis of diabetes with cancer patients from 2006 to 2013
| Variable | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | 1–59 years | ≥60 years | ||||||||
| Diabetes or cancer | 3,656 | 6,557 | 4,882 | 8,911 | 5,431 | 10,070 | 6,420 | 12,472 | 7,413 | 14,049 | 8,711 | 16,398 | 9,921 | 19,029 | 11,172 | 21,631 | |||||||
| Diabetes | 411 | 2,011 | 583 | 3,028 | 705 | 3,368 | 797 | 4,203 | 930 | 4,787 | 1,210 | 5,699 | 1,931 | 6,824 | 1,993 | 7,711 | |||||||
| Diabetes & cancer | 16 | 204 | 45 | 286 | 43 | 357 | 43 | 484 | 53 | 607 | 90 | 813 | 118 | 1,219 | 127 | 1,496 | |||||||
| P | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | <0.005 | |||||||||||||||
| OR | 7.11 | 3.48 | 4.48 | 5.79 | 6.04 | 4.80 | 5.39 | 6.08 | |||||||||||||||
OR, odds ratio.
Figure 1The age distribution of diabetes with cancer patients.
Figure 2The gender distribution of diabetes with cancer patients.
The top five cancer disease for diabetes patients
| No. | Gender | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Male | Non-Hodgkin’s lymphoma | Liver cancer | Liver cancer | Liver cancer | Liver cancer | Liver cancer | Liver cancer | Liver cancer |
| Female | Breast cancer | Breast cancer | Uterine fibroids | Uterine fibroids | Uterine fibroids | Colorectal cancer | Gastric cancer | Colorectal cancer | |
| 2 | Male | Multiple myeloma | Prostate cancer | Pancreatic cancer | Colon cancer | Colon cancer | Pancreatic cancer | Esophageal | Prostate cancer |
| Female | Pancreatic cancer | Uterine fibroids | Breast cancer | Gastric cancer | Cardiac adenocarcinoma | Lymphoma | Hodgkin’s lymphoma | Uterine fibroids | |
| 3 | Male | Gastric cancer | Non-Hodgkin’s lymphoma | Lung cancer | Colorectal cancer | Prostate cancer | Lung adenocarcinoma | Lung cancer | Esophageal cancer |
| Female | Uterine fibroids | Liver cancer | Lung cancer | Breast cancer | Ovarian cancer | Ovarian cancer | Uterine fibroids | Breast cancer | |
| 4 | Male | Prostate cancer | Lung cancer | Cardiac adenocarcinoma | Lung adenocarcinoma | Pancreatic cancer | Colon cancer | Prostate cancer | Pancreatic cancer |
| Female | Bladder cancer | Pancreatic cancer | Liver cancer | Lung cancer | Pancreatic cancer | Hodgkin’s lymphoma | Colorectal cancer | Lung cancer | |
| 5 | Male | Lung cancer | Gastric cancer | Gastric cancer | Gastric cancer | Colorectal cancer | Prostate cancer | Gastric cancer | Colorectal cancer |
| Female | Multiple myeloma | Ovarian cancer | Gastric cancer | Pancreatic cancer | Colorectal cancer | Cardiac adenocarcinoma | Ovarian cancer | Pancreatic cancer |
Basic/clinical characteristics of study participants ()
| General Indexes | Normal (n=38,168) | Gastrointestinal cancer (n=8,055) | Total (n=46,223) |
|---|---|---|---|
| Male, N (%) | 19,744 (51.7) | 4,329 (53.7) | 24,073 (52.1) |
| Female, N (%) | 18,424 (48.3) | 3,726 (46.3) | 22,150 (47.9) |
| Age (years) | 52.33±11.98 | 63.26±13.03 | 57.23±9.17 |
| BMI (kg/m2) | 26.17±4.68 | 27.01±4.02 | 26.38±3.68 |
| SBP (mmHg) | 136.36±16.98 | 137.80±16.43 | 137.82±14.61 |
| DBP (mmHg) | 84.24±11.73 | 83.38±10.12 | 83.24±9.67 |
| FBG (mmol/L) | 8.01±2.82 | 6.41±1.58 | 7.43±2.57 |
| HbA1c (%) | 7.84±1.48 | 8.12±2.63 | 8.04±1.49 |
| ALT (U/L) | 29.75±13.80 | 26.11±13.44 | 28.45±6.03 |
| AST (U/L) | 32.10±15.36 | 27.64±11.67 | 30.51±7.80 |
| TC (mmol/L) | 4.39±1.25 | 4.05±1.31 | 4.27±1.27* |
| TG (mmol/L) | 1.53±0.95 | 1.11±0.88 | 1.38±0.85* |
| HDL (mmol/L) | 1.13±0.32 | 1.18±0.29 | 1.15±0.31* |
| LDL (mmol/L) | 2.73±0.91 | 2.55±0.83 | 2.67±0.88* |
| Cr (ìmol/L) | 87.40±17.89 | 73.46±15.64 | 82.43±12.01 |
| UA (ìmol/L) | 321.57±107.23 | 292.88±87.39 | 311.36±76.54 |
*, P<0.001 was considered as statistically significant difference. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HbA1c, glycosylated hemoglobin; ALT, glutamic-pyruvic transaminase; AST, glutamic oxalacetic transaminase; TC, total cholesterol; TG, triglycerides; HDL, high density lipoprotein; LDL, low density lipoprotein; Cr, creatinine; UA, uric acid.
The comparison of blood lipids between normal and gastrointestinal cancer groups
| General Indexes | Normal | Gastrointestinal cancer |
| P |
|---|---|---|---|---|
| TC (mmol/L) | 4.39±1.25 | 4.05±1.31 | 17.69 | 0.000* |
| TG (mmol/L) | 1.53±0.95 | 1.11±0.88 | 27.77 | 0.000* |
| HDL (mmol/L) | 1.13±0.32 | 1.18±0.29 | 14.29 | 0.000* |
| LDL (mmol/L) | 2.73±0.91 | 2.55±0.83 | 14.64 | 0.000* |
The t-test with different samples was adopted for comparison between groups. *, P<0.001 was considered as statistically significant difference. TC, total cholesterol; TG, triglycerides; HDL, high density lipoprotein; LDL, low density lipoprotein.
Number of patients with simple diabetes with different total cholesterol ranges and number of diabetic patients with gastrointestinal tumors
| TC (mmol/L) | Patients | Patients with malignant tumors |
|---|---|---|
| TC ≤1 | 57 | 20 |
| 1< TC ≤2 | 693 | 205 |
| 2< TC ≤3 | 3,873 | 951 |
| 3< TC ≤4 | 10,759 | 2,393 |
| 4< TC ≤5 | 12,123 | 2,426 |
| 5< TC ≤6 | 6,539 | 1,274 |
| 6< TC ≤7 | 3,290 | 600 |
| 7< TC ≤8 | 499 | 95 |
| 8< TC ≤9 | 153 | 33 |
| 9< TC ≤10 | 71 | 18 |
| 10< TC ≤11 | 38 | 12 |
| TC >11 | 73 | 28 |
Chi-square test: P=0.000. TC, total cholesterol.
Figure 3The correlation curve between total cholesterol level and gastrointestinal cancer prevalence in DM patients. DM, diabetes mellitus.
Figure 4The average daily cost of hospitalization.